| Dr John Eric Vance, MD | |
|
2017 Jefferson St Sw, Roanoke, VA 24014-2419 | |
| (540) 853-0900 | |
| (540) 853-0518 |
| Full Name | Dr John Eric Vance |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 2017 Jefferson St Sw, Roanoke, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033284427 | NPI | - | NPPES |
| 7706655Y0NH01 | Other | NH | BHN |
| 99003227 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 8147 (New Hampshire) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0101252210 (Virginia) | Primary |
| Entity Name | Carilion Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730123472 PECOS PAC ID: 9830096585 Enrollment ID: O20040107000472 |
News Archive
Scientists at Nanyang Technological University, Singapore have discovered that antibiotics can continue to be effective if bacteria's cell-to-cell communication and ability to latch on to each other are disrupted.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
With the third and largest of the U.S. tobacco companies planning an e-cigarette product launch this fall, this next frontier for "Big Tobacco" provides renewed presence in a declining marketplace. It's also a potential gateway to new smokers, particularly among teens and in emerging/foreign markets, according to behavioral scientists at The University of Texas MD Anderson Cancer Center.
Cancer Research Technology, the commercial arm of Cancer Research UK, has today launched Acublate Limited, a spin-out company which will develop a next-generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Eric Vance, MD 213 S Jefferson St Ste 1006, Roanoke, VA 24011-1713 Ph: () - | Dr John Eric Vance, MD 2017 Jefferson St Sw, Roanoke, VA 24014-2419 Ph: (540) 853-0900 |
News Archive
Scientists at Nanyang Technological University, Singapore have discovered that antibiotics can continue to be effective if bacteria's cell-to-cell communication and ability to latch on to each other are disrupted.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
With the third and largest of the U.S. tobacco companies planning an e-cigarette product launch this fall, this next frontier for "Big Tobacco" provides renewed presence in a declining marketplace. It's also a potential gateway to new smokers, particularly among teens and in emerging/foreign markets, according to behavioral scientists at The University of Texas MD Anderson Cancer Center.
Cancer Research Technology, the commercial arm of Cancer Research UK, has today launched Acublate Limited, a spin-out company which will develop a next-generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.
› Verified 5 days ago
Dr. Badr Ratnakaran, MBBS Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-981-8025 Fax: 540-853-0511 | |
Carlos Mora, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-224-5170 Fax: 540-985-9427 | |
John H Draeger, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-853-0900 Fax: 540-853-0518 | |
Fahim Fahim, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3517 Brandon Ave Sw, Roanoke, VA 24018 Phone: 540-981-1102 Fax: 540-344-4169 | |
Dr. John Gordon Burch, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4431 Starkey Rd, Roanoke, VA 24018 Phone: 540-342-0211 Fax: 540-344-5543 | |
Sooraj John, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-981-8025 Fax: 540-853-0511 |